Neutralizing ceramide: A major breakthrough or yet another marginal target for the treatment of acute lung injury?

Pediatric Research

Volumn 57, Issue 3, 2005, Pages 319-321

  Mercier, Jean Christophe ^a   Dinh Xuan, A Tuan ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CERAMIDE; DEXAMETHASONE; IMIPRAMINE; PROSTAGLANDIN SYNTHASE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; THROMBOCYTE ACTIVATING FACTOR; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; BLOOD VESSEL PERMEABILITY; BRONCHOSPASM; CELL MEMBRANE; ENZYME ACTIVITY; ENZYME MECHANISM; HYDROLYSIS; HYDROSTATIC PRESSURE; LEUKOCYTE; LUNG EDEMA; LUNG PERFUSION; LUNG VASOCONSTRICTION; LUNG WEIGHT; NONHUMAN; NOTE; PRIORITY JOURNAL; WILD TYPE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BRIDGED COMPOUNDS; CERAMIDES; EDEMA; HUMANS; IMIPRAMINE; MICE; PHOSPHODIESTERASE INHIBITORS; RESPIRATORY DISTRESS SYNDROME, ADULT; SPHINGOMYELIN PHOSPHODIESTERASE; THIONES;

EID: 14344257238     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000153948.44951.5B     Document Type: Note

References (13)

1. Rinaldo JE, Rogers RM 1982 Adult respiratory-distress syndrome: changing concepts of lung injury and repair. N Engl J Med 306:900-909
2. Ware LB, Matthay MA 2000 The acute respiratory distress syndrome. N Engl J Med 342:1334-1349
3. Nagase T, Ishii S, Kume K, Uozumi N, Izumi T, Ouchi Y, Shimizu T 1999 Platelet-activating factor mediates acid-lung injury in gentically engineered mice. J Clin Invest 104:1071-1076
4. Tjoeker LW, Wilder C, Eberhardt C, Stafforinit DM, Dietsch G, Schimpf B, Hooper S, Le Trong H, Cousens LS, Zimmerman GA, Yamadat Y, McIntyre TM, Frescott SM, Gray PW 1995 Anti-inflammatory properties of platelet-activating factor acetyl-hydrolase. Nature 374:549-553
5. Schuster DP, Metzler M, Opal S, Lowry S, Balk R, Abraham E, Levy H, Slotman G, Coyne E, Souza S, Pribble J 2003 Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis : phase IIb, multicenter, randomised, placebo-controlled, clinical trial. Crit Care Med 31:1612-1619
6. Falk S, Goggel R, Heydasch U, Brasch F, Muller KM, Wendel A, Uhlig S 1999 Quinolines attenuate PAF-induced pulmonary presser responses and edema formation. Am J Resp Crit Care Med 160:1734-1742
7. Balsinde J, Balboa MA, Dennis EA 1997 Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomylin synthesis. J Biol Chem 272:20273-20377
8. Luberto C, Hannun YA 1998 Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C? J Biol Chem 273:14550-14559
9. Spiegel S, Milstien 2003 Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4:397-407
10. Saba JD, Hla T 2004 Point-counterpoint of sphingosine-1-phosphate metabolism. Circ Res 94:724-734
11. Dbaibo GS, Hannun YA 1998 Signal transaction and the regulation of apoptosis: roles of ceramide. Apoptosis 3:317-334
12. Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, Vogel P, Rothe G, Schmitz G 2003 Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 44:754-761
13. Rauvala H, Mallman M 1984 Glycolipid accumulation in bronchoalveolar space in adult respiratory distress syndrome J Lipid Res 25:1257-1262